Optimum Perspectives

Optimum Strategic Communications•www.optimumcomms.com

Optimum Insights: Interviews with industry leaders of the healthcare sector in regular episodes highlighting the latest innovation and developments in life sciences.

Follow us on Linkedin and Twitter for news and highlights on the life sciences industry. Reach out via our contact page on our website: www.optimumcomms.com

Hosted on Acast. See acast.com/privacy for more information.

Last refreshed: August 21st, 2025 at 8:29 PM ⓘ

Follow this podcast in the Metacast mobile app to refresh it and see new episodes.

Follow on

Apple Podcasts

Spotify

RSS

Podcasts are better in Metacast mobile app

Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Renée Aguiar-Lucander, CEO of Calliditas Therapeutics: Blazing a trail in rare diseases

How do you take a tiny private Swedish biotech and turn it into a successful, publicly-listed company operating on both sides of the Atlantic, in just six years? Listen to Renée Aguiar-Lucander, CEO of Calliditas Therapeutics, tell Optimum’s Richard Staines how they brought TARPEYO, the first FDA-approved drug for the rare kidney disease primary IgA nephropathy, to market. She describes her ‘incredible journey’ growing the firm from less than 10 staff to more than 200, taking it public in Europe...

Jun 13, 2023•23 min•Ep. 4

An interview with Dan Mahony, UK Government Life Sciences Envoy, by Optimum’s Eva Haas

In this episode, our in-house IR expert, and ex-Fund Manager Eva Haas interviewed Dan Mahony, Chairman of the BioIndustry Association (BIA), following his appointment as UK Life Sciences Investment Envoy to hear his plans for championing the UK’s Life Sciences industry. Read the insight piece here: An interview with Dan Mahony, UK Government Life Sciences Envoy by Optimum’s Eva Haas https://www.optimumcomms.com/podcast Follow us and subscribe for new episodes highlighting the latest innovation a...

Apr 27, 2023•23 min•Ep. 3

Versameb: Revolutionizing SUI therapy with mRNA technology

Stress urinary incontinence (SUI) is a common and debilitating problem for many women, particularly after childbirth or in later years. Yet, despite this, treatment options are limited, held back by a lack of research into medical products focused on women’s health. Versameb , hopes to change this with a novel mRNA therapy that rebuilds the urinary sphincter and is about to enter clinical trials. In this podcast, Richard Staines from Optimum Strategic Communications caught up with the Versameb t...

Apr 19, 2023•13 min•Ep. 2

CellCentric's new oral cancer therapy inobrodib

Our host Richard Staines , Account Director at Optimum, discusses the latest clinical findings from inobrodib, an oral cancer therapy developed by the UK biotech CellCentric . In our first episode, we hear from Jan Ross, a patient who discusses the pressing need for new therapies for multiple myeloma with fewer side effects. We also talked to top cancer experts – Tim Somervaille of the Christie Hospital in Manchester, Karen Knudsen , Chief Executive of the American Cancer Society, Dr Leif Bergsa...

Jan 23, 2023•9 min•Season 1Ep. 1

← Prev

For the best experience, listen in Metacast app for iOS or Android